Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

PTH-CBD helps reduce hair loss in mice by stimulating hair growth directly.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

The combination therapy was effective and well-tolerated, especially in young patients.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

The method effectively delivers vaccines through the skin without needles.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

A man had bad reactions to a hair loss treatment called DNCB.